ArticleJA clinical reports2025
Perioperative anaphylaxis due to intravenous tranexamic acid following cutaneous exposure.
Article in JA clinical reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundTranexamic acid (TXA) is widely used to prevent surgical bleeding; further, it has been recently applied in cosmetic dermatology. TXA-induced anaphylaxis is very rare; however, most reported cases occur upon initial administration. CASE PRESENTATION: This case report describes a 41-year-old man with atopic dermatitis who developed TXA-induced anaphylaxis during induction of general anesthesia for spinal surgery. Intradermal testing using TXA yielded reproducible positive reactions, while other tested drugs yielded negative results. His medical history revealed repeated episodes of dermatitis 1 year prior after applying a topical skin-lightening cream containing TXA. This suggested that prior percutaneous exposure may have contributed to sensitization.
conclusionsOur findings suggest a possible relationship between prior topical exposure to TXA and perioperative anaphylaxis. Although TXA-induced anaphylaxis is extremely rare, the increasing use of TXA in both surgical and cosmetic contexts may increase opportunities for exposure. Therefore, clinicians should be aware of this potential risk.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.